Accueil   Diary - News   All news CALIPSO: revolutionizing the management of bioproduction processes in healthcare

CALIPSO: revolutionizing the management of bioproduction processes in healthcare

 

 

  • A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors.
  • An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence.

 

 

Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, and CentraleSupélec announce the launch of the project CALIPSO (Capteurs en Ligne de Procédés et Solutions Innovantes en Bioproduction, or Online Process Sensors and Innovative Bioproduction Solutions). This project, with a total budget of nearly €17.5M, is publicly backed to the tune of €M 8.059 as part of the PSPC n°9 call to tender, operated on behalf of the State by Bpifrance through the Future Investment Program (PIA). The objective of the CALIPSO project is to develop a new generation of tools that will revolutionize R&D methodology and the management of industrial bioproduction processes, thus enabling productivity gains up to a factor 10.  

 

 

 

Read the press release